Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

OrbiMed Raising $500 Million for Asia Healthcare Fund

publication date: Feb 27, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
OrbiMed Advisors is raising $500 million for its second Asia healthcare private equity fund, which will be invested mainly in China and India. That’s up from $300 million rumored as recently as last fall. The company expects to close Asia Partners II later this year, just about the time it will have its $188 million Asia Partners I fund fully invested. OrbiMed, headquartered in the US, specializes in healthcare investments around the globe. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors